Cumberland Pharma rises after FDA approves broader use of pain drug

Cumberland Pharmaceuticals

16/04/2026 14:16

** Shares of drugmaker Cumberland Pharmaceuticals CPIX.O rise about 12.5% to $3.60 premarket

** Co says it received FDA approval for wider use of Caldolor, an IV form of ibuprofen, for pain after surgery in adults and children as young as three months

** Approval allows use of Caldolor for mild-to-moderate pain and for severe post-surgery pain alongside opioids

** Co adds that drug can be used to reduce fever and is positioned to cut reliance on addictive opioid painkillers

** As of last close, stock down ~20% YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))